ONP [Orient Paper] 10-Q:

[] [I, Zhenyong Liu certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; ss 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [I, Winston C. Yen, certify that: 1. I have reviewed this Quarterly Report on Form 10-Q of Orient Paper, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Zhenyong Liu Chief Executive Officer EX-32.1 4 v344505_ex32-1.htm EX-32.1] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Winston C. Yen Chief Financial Officer (principal financial and accounting officer) EX-32.2 5 v344505_ex32-2.htm EX-32.2]

By | 2016-03-19T22:31:44+00:00 May 15th, 2013|Categories: Chinese Stocks, ONP, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q: FORM 10-Q (Mark One) x For the quarterly

[FORM 10-Q (Mark One) x For the quarterly period ended March 31, 2013 o For the transition period from _______________ to _______________ Tianyin Pharmaceutical Co., Inc. Delaware (State or other jurisdiction of 23rd Floor, Unionsun Yangkuo Plaza No. 2, Block 3, Renmin Road South Chengdu, P. R. China, 610041 +0086-028-86154737 (Address, including zip code, and telephone number, x o x] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, James Jiayuan Tong, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2013 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. James Jiayuan Tong James Jiayuan Tong Chief Financial Officer, Director]

By | 2016-03-27T18:25:31+00:00 May 15th, 2013|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: (Original Filing)

[JOINT FILING AGREEMENT Dated: May 15, 2013 WP X Biologics LLC Scott A. Arenare Attorney-in-Fact* WARBURG PINCUS PRIVATE EQUITY X, L.P.] [REGISTRATION RIGHTS AGREEMENT Agreement Company Purchaser This Registration Rights Agreement (this “ RECITALS Selling Stockholder Purchase Agreement Shares Common Stock The Company and the Purchaser hereby agree as follows: Definitions 1. 2009 Holders “ 2010 Holders “ Advice “ Affiliate “ Agreement “ Business Day “ Company “ Commission “ Common Stock “ Effectiveness Date “ Effectiveness Period “ Exchange] [ESCROW AGREEMENT WP X Biologics LLC Ms. Lin Ling Li WHEREAS, NOW THEREFORE 1. Appointment The Parties hereby appoint the Escrow Agent as their escrow agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment under the terms and conditions set forth herein. 2. Escrow Document 2.1 Party B agrees to deposit with the Escrow] [AGREEMENT Agreement WP X Ms. Li Mr. Lin Parties Party This AGREEMENT (this “ WHEREAS Share Purchase Agreement WHEREAS Escrow Agreement Escrow Agent WHEREAS NOW, THEREFORE 1. Definitions 2. Delivery of Release Notice (a) HK Lawsuit Resolution Plaintiffs (b) Within ten (10) Business Days of the HK Lawsuit Resolution, the Parties shall deliver the Release Notice to the Escrow Agent] [CUSIP No. 16938C106 2 1. Names of reporting persons.]

By | 2016-04-03T00:26:57+00:00 May 15th, 2013|Categories: CBPO, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

AMCF [Andatee China Marine Fuel Services] 10-Q: (Original Filing)

[] [CERTIFICATION I, An Fengbin, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Wang Hao, certify that: 1. I have reviewed this Form 10-Q of Andatee China Marine Fuel Service Corporation; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. An Fengbin President, Chief Executive Officer] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company for said period. Wang Hao Chief Financial Officer]

By | 2016-03-13T18:53:59+00:00 May 15th, 2013|Categories: AMCF, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments
Read More

EDS [Exceed Co] 6-K: (Original Filing)

[Exceed Company Ltd. 2013 FiRST quarter financial Results Fujian, China, May 15, 2013 - Exceed Company Ltd. (NASDAQ: EDS) (“Exceed” or “the Company”), the owner and operator of the “Xidelong” brand - one of the leading domestic sportswear brands in China, today released its unaudited financial results for the first quarter ended March 31, 2013. Financial Highlights – 2013 First] []

By | 2016-03-21T01:31:11+00:00 May 15th, 2013|Categories: Chinese Stocks, EDS, SEC Original|Tags: , , , , , |0 Comments
Read More

LFC [CHINA LIFE INSURANCE CO] 6-K: (Original Filing)

[(A joint stock limited company incorporated in the People’s Republic of China with limited liability) (Stock code: 2628) ANNOUNCEMENT OF PREMIUM INCOME CIRC Reference is made to the Company’s announcement dated 27 August 2004. The accumulated premium income of the Company for the period from 1 January 2013 to 30 April 2013 was about RMB135.6 billion. The figure is to] [Description 99.1 Announcement, dated May 15, 2013]

By | 2016-03-28T03:31:27+00:00 May 15th, 2013|Categories: Chinese Stocks, LFC, SEC Original|Tags: , , , , , |0 Comments
Read More

CBPO [China Biologic Products] SC 13D/A: JOINT FILING AGREEMENT Dated: May 15, 2013 WP

[JOINT FILING AGREEMENT Dated: May 15, 2013 WP X Biologics LLC Scott A. Arenare Attorney-in-Fact* WARBURG PINCUS PRIVATE EQUITY X, L.P.] [REGISTRATION RIGHTS AGREEMENT Agreement Company Purchaser This Registration Rights Agreement (this “ RECITALS Selling Stockholder Purchase Agreement Shares Common Stock The Company and the Purchaser hereby agree as follows: Definitions 1. 2009 Holders “ 2010 Holders “ Advice “ Affiliate “ Agreement “ Business Day “ Company “ Commission “ Common Stock “ Effectiveness Date “ Effectiveness Period “ Exchange] [ESCROW AGREEMENT WP X Biologics LLC Ms. Lin Ling Li WHEREAS, NOW THEREFORE 1. Appointment The Parties hereby appoint the Escrow Agent as their escrow agent for the purposes set forth herein, and the Escrow Agent hereby accepts such appointment under the terms and conditions set forth herein. 2. Escrow Document 2.1 Party B agrees to deposit with the Escrow] [AGREEMENT Agreement WP X Ms. Li Mr. Lin Parties Party This AGREEMENT (this “ WHEREAS Share Purchase Agreement WHEREAS Escrow Agreement Escrow Agent WHEREAS NOW, THEREFORE 1. Definitions 2. Delivery of Release Notice (a) HK Lawsuit Resolution Plaintiffs (b) Within ten (10) Business Days of the HK Lawsuit Resolution, the Parties shall deliver the Release Notice to the Escrow Agent] [CUSIP No. 16938C106 2 1. Names of reporting persons.]

By | 2016-04-03T00:27:51+00:00 May 15th, 2013|Categories: CBPO, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar